Distinct cerebral cortical perfusion patterns in idiopathic normal-pressure hydrocephalus
- PMID: 36102811
- PMCID: PMC9783416
- DOI: 10.1002/hbm.25974
Distinct cerebral cortical perfusion patterns in idiopathic normal-pressure hydrocephalus
Abstract
The aims of the study are to evaluate idiopathic normal-pressure hydrocephalus (INPH)-related cerebral blood flow (CBF) abnormalities and to investigate their relation to cortical thickness in INPH patients. We investigated cortical CBF utilizing surface-based early-phase 18 F-florbetaben (E-FBB) PET analysis in two groups: INPH patients and healthy controls. All 39 INPH patients and 20 healthy controls were imaged with MRI, including three-dimensional volumetric images, for automated surface-based cortical thickness analysis across the entire brain. A subgroup with 37 participants (22 INPH patients and 15 healthy controls) that also underwent 18 F-fluorodeoxyglucose (FDG) PET imaging was further analyzed. Compared with age- and gender-matched healthy controls, INPH patients showed statistically significant hyperperfusion in the high convexity of the frontal and parietal cortical regions. Importantly, within the INPH group, increased perfusion correlated with cortical thickening in these regions. Additionally, significant hypoperfusion mainly in the ventrolateral frontal cortex, supramarginal gyrus, and temporal cortical regions was observed in the INPH group relative to the control group. However, this hypoperfusion was not associated with cortical thinning. A subgroup analysis of participants that also underwent FDG PET imaging showed that increased (or decreased) cerebral perfusion was associated with increased (or decreased) glucose metabolism in INPH. A distinctive regional relationship between cerebral cortical perfusion and cortical thickness was shown in INPH patients. Our findings suggest distinct pathophysiologic mechanisms of hyperperfusion and hypoperfusion in INPH patients.
Keywords: cerebral blood flow; idiopathic normal-pressure hydrocephalus; magnetic resonance imaging; positron emission tomography.
© 2022 The Authors. Human Brain Mapping published by Wiley Periodicals LLC.
Conflict of interest statement
The authors declare they have no competing interests.
Figures




References
-
- Barthel, H. , Gertz, H. J. , Dresel, S. , Peters, O. , Bartenstein, P. , Buerger, K. , Hiemeyer, F. , Wittemer‐Rump, S. M. , Seibyl, J. , Reininger, C. , Sabri, O. , & Florbetaben Study, G . (2011). Cerebral amyloid‐beta PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: A multicentre phase 2 diagnostic study. Lancet Neurology, 10, 424–435. - PubMed
-
- Bergeret, S. , Queneau, M. , Rodallec, M. , Curis, E. , Dumurgier, J. , Hugon, J. , Paquet, C. , Farid, K. , & Baron, J. C. (2021). [18F]FDG PET may differentiate cerebral amyloid angiopathy from Alzheimer's disease. European Journal of Neurology, 28, 1511–1519. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources